Close Menu

Kreatech

NEW YORK (GenomeWeb News) – Leica Biosystems today announced it has acquired Kreatech Diagnostics for an undisclosed amount.

NEW YORK (GenomeWeb News) – Exact Sciences said in its 10-K filing with the US Securities and Exchange Commission this week that in December it entered into an amendment to a licensing agreement pursuant to which Hologic granted the company a non-exclusive worldwide license to certain Hologic pat

NEW YORK (GenomeWeb News) – Kreatech Diagnostics and Oridis Biomarkers today said that they will co-develop and commercialize DNA-FISH assays for oncology applications.

NEW YORK (GenomeWeb News) – Rubicon Genomics has signed an agreement to provide Kreatech Diagnostics with its OmniPlex-D whole-genome amplification technology.

NEW YORK (GenomeWeb News) – Kreatech Diagnostics today announced a distribution agreement covering Iris Sample Processing's automated fluorescent in situ hybridization sample preparation product.

The partners plan to co-develop fluorescent in situ hybridization probes for genetic targets in bone and soft tissue tumors.

The deal covers Kreatech's ULS technology that features a two-step labeling procedure "that allows the use of a broad range of fluorescent labels and haptens."

Judd Jessup, Mark McGowan, Oliver Yeh, Robert Marchmont, Rolf Hansen

Pairings: Aug 11, 2010

Premium

Rolf Hansen, Lawrence Corey

Movers & Shakers: Aug 6, 2010

Premium

Charles Wagner, Rolf Hansen, Lawrence Corey

Pages

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.